Mono Pharmacare Limited is engaged in the marketing and distribution of pharmaceutical products, operating since 1994. Their portfolio includes antibiotics, antifungals, skincare, and cardiac drugs, manufactured through contract partners.

The company transitioned from a partnership to a public limited entity in October 2022, indicating an organized structural evolution for better market access and capital acquisition.

In August 2023, Mono Pharmacare launched an IPO raising Rs 14.84 crore, suggesting strategic financial planning to fuel future growth and opportunities.

The company has actively acquired related entities, consolidating operational strengths and expanding market coverage in the industry.

Mono Pharmacare is led by Promoters Panilam and Supal Lakhatariya, who have been strategically acquiring related firms to bolster the company's value proposition.